Farallon Capital Management’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $5.41M | Hold |
|
|||||
|
2024
Q2 | $5.55M | Hold |
|
|||||
|
2024
Q1 | $7.18M | Sell |
|
|||||
|
2023
Q4 | $90.8M | Buy |
|
|||||
|
2023
Q3 | $641K | Hold |
|
|||||
|
2023
Q2 | $710K | Sell |
|
|||||
|
2023
Q1 | $33M | Sell |
|
|||||
|
2022
Q4 | $78M | Buy |
|
|||||
|
2022
Q3 | $78.5M | Sell |
|
|||||
|
2022
Q2 | $88.2M | Buy |
|
|||||
|
2022
Q1 | $69.3M | Sell |
|
|||||
|
2021
Q4 | $98.9M | Sell |
|
|||||
|
2021
Q3 | $97.7M | Sell |
|
|||||
|
2021
Q2 | $56.9M | Buy |
|
|||||
|
2021
Q1 | $58.1M | Buy |
|
|||||
|
2020
Q4 | $49.9M | Buy |
|
|||||
|
2020
Q3 | $46.5M | Buy |
|
|||||
|
2020
Q2 | $35.4M | Buy |
|
|||||
|
2020
Q1 | $7.37M | Buy |
|